SVB Leerink analyst Danielle Antalffy reiterated an Outperform rating on CytoSorbents (NASDAQ: CTSO) after the company announced that the FDA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE